Curadev Pharma announces the formation of its Clinical Advisory Group

Noida (Uttar Pradesh) [India], January 4 (ANI/PRNewswire): Curadev Pharma has created a Clinical Advisory Group (CAG) comprising eminent oncologists to provide guidance in the design and execution of immune-oncology clinical trials with CRD3874, its lead non-nucleoside, allosteric small molecule STING agonist

Related Keywords

United States ,Mumbai ,Maharashtra ,India ,Bengaluru ,Karnataka ,United Kingdom ,Navin Khattry ,Jacob Sands ,Noida Uttar Pradesh ,Arjun Surya ,Curadev Pharma ,K Govind Babu ,Eileen Parkes ,Clinical Advisory Group ,University Of Oxford ,Indian Myeloma Group Image ,Clinical Research Center ,Federation Of Oncology ,Johns Medical College ,Harvard University ,Group Leader ,Dana Farber Cancer Institute ,Clinical Research Centre ,Uttar Pradesh ,Deputy Director ,Tata Memorial ,Indian Myeloma Group ,Innate Tumor Immunology ,Thoracic Oncology ,Medical Oncologist ,Indian Society ,Pediatric Oncology ,South Asian ,India Summit ,Curadev ,Dharma ,Nnounces ,The ,Formation ,F ,Its ,Linical ,Advisory ,Group ,News ,Ews India ,